111 results
Page 5 of 6
6-K
EX-99.1
1ywx0 h6j8dw
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
6-K
EX-99.3
j4neidzlkvstgk5ne
13 Nov 19
Report of Foriegn Private Issuer
5:18pm
6-K
EX-99.1
7epcnaavdn
11 Sep 19
Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy
4:50pm
6-K
EX-99.2
bb7sv3
7 Aug 19
Current report (foreign)
1:58pm
424B4
oy8vfai5g25o3
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
mfoj2p6 rix
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-1.1
v49d7t8cbd2kf35q
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-10.14
tsx z3fvvnme
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
p055fygu
24 Jun 19
Registration statement (foreign)
4:04pm
6-K
EX-99.1
56qgy 8a4
19 Jun 19
Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel
6:02am
6-K
EX-99.1
xapqwu5jek3jyd3j
5 Jun 19
Gamida Cell Bolsters Management Team with Appointment of Tracey Lodie, Ph.D., as Chief Scientific Officer
2:43pm
6-K
EX-99.1
dg6 e90c73sqtyu759c
31 May 19
Gamida Cell Announces Data for Omidubicel Presented at the International Society for Cellular and Gene Therapy 2019 Annual Meeting
8:45am
6-K
EX-99.3
gjxggv
7 May 19
Current report (foreign)
1:57pm
6-K
EX-99.1
rk757
21 Mar 19
Gamida Cell Nominates Two Healthcare Industry Veterans to Its Board of Directors
5:23pm
20-F
d2a1bud tog9ps
25 Feb 19
Annual report (foreign)
5:08pm
6-K
EX-99.1
opmy65y jt
25 Feb 19
Gamida Cell Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
4:15pm
6-K
EX-99.1
gaow91r
25 Feb 19
Gamida Cell Announces Immune Reconstitution Data from Completed Phase 1/2 Clinical Study of NiCord® Presented at 2019 TCT Annual Meeting
6:08am
6-K
EX-99.1
lp1bikbq2oyv lq8v
21 Feb 19
Current report (foreign)
2:06pm
6-K
EX-99.1
d1rmt7ixnq
19 Feb 19
Gamida Cell Announces Agreement with Editas Medicine to Evaluate Use of CRISPR Genome Editing Technology in NAM-NK Cells
2:05pm
DRS
qa9n17ii
15 Feb 19
Draft registration statement
12:00am